Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing
Andrew M. Atz, MDa,
Ian Adatia, FRCP(C)b,
James E. Lock, MD, FACCc and
David L. Wessel, MDc
a Department of Cardiology, Childrens Hospital, Boston, Massachusetts, USA
b Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA
c Harvard Medical School, Boston, Massachusetts, USA

View larger version (39K):
[in a new window]
|
Figure 1 Pulmonary vascular resistance (PVR) (mean ± SE) differed across the four study conditions in group 1 (p < 0.0001); PVR was lower in oxygen (O2) compared with room air (RA) (*) and was lower in nitric oxide in RA (NO+RA) compared with RA ( ) (p < 0.05 for both).
|
|

View larger version (64K):
[in a new window]
|
Figure 2 Individual patients percentage change in PVR with O2 is plotted against percentage change in PVR with NO+RA. Using a 20% decrease in PVR as a marker for responsiveness, some patients responded to one drug only. Neither O2 nor NO+RA identified all patients with pulmonary vasoreactivity. Abbreviations as in Figure 1.
|
|

View larger version (29K):
[in a new window]
|
Figure 3 Pulmonary vascular resistance (mean ± SE) differed across the three study conditions in group 2 (p < 0.0001); PVR was lower in O2 compared with RA (*) and was lower in NO+O2 compared with RA (*) and O2 ( ) (p < 0.05 for all comparisons). Abbreviations as in Figure 1.
|
|
|